Last quarter (Q ), Vicapsys Life Sciences's total revenue was $―, a decrease of ― from the same quarter last year. In Q, Vicapsys Life Sciences's net income was $-240.34K. See Vicapsys Life Sciences’s key income statements, including revenue, expenses, profit, and income.

Income Statement	TTM	Dec 22	Dec 21	Dec 20	Dec 19	Dec 09
Total Revenue	-	-	-	$ 0.00	$ 0.00	$ 7.78M
Cost of Revenue	-	-	-	-	-	$ 7.24M
Gross Profit	-	-	-	-	-	$ 544.52K
Operating Expense	$ -392.77K	$ 644.56K	$ 336.87K	$ 765.84K	$ 1.03M	$ 1.90M
Operating Income	$ -246.45K	$ -644.56K	$ -336.87K	$ -765.84K	$ -1.03M	$ -1.35M
Net Non Operating Interest Income Expense	$ -9.95K	-	-	-	-	$ -320.59K
Other Income Expense	$ 54.96K	$ -340.23K	$ -100.00K	-	-	$ 4.32K
Pretax Income	$ -1.08M	$ -984.79K	$ -236.87K	$ -765.84K	$ -1.03M	$ -1.67M
Tax Provision	$ -22.19K	$ -22.19K	$ -908.00	$ 0.00	$ 0.00	$ 0.00
Earnings From Equity Interest Net Of Tax	-	-	-	-	-	-
Net Income Common Stockholders	$ -785.42K	$ -988.34K	$ -236.87K	$ -765.84K	$ -1.57M	$ -1.67M
Basic EPS	$ -0.03	$ -0.03	$ -0.01	$ -0.10	$ -0.13	$ -4.80
Diluted EPS	-	$ -0.03	$ -0.01	$ -0.10	$ -0.13	$ -4.80
Basic Average Shares	$ 134.88M	$ 30.58M	$ 17.66M	$ 17.48M	$ 11.40M	$ 346.80K
Diluted Average Shares	$ 104.31M	$ 30.58M	$ 17.66M	$ 17.48M	$ 11.40M	$ 346.80K
Dividend Per Share	-	-	-	-	-	-
Total Operating Income As Reported	-	-	-	-	-	-
Reported Normalized Basic E P S	-	-	-	-	-	-
Reported Normalized Diluted E P S	-	-	-	-	-	-
Rent Expense Supplemental	-	-	-	-	-	-
Total Expenses	$ -392.77K	$ 644.56K	$ 336.87K	$ 765.84K	$ 1.03M	$ 9.14M
Net Income From Continuing And Discontinued Operation	$ -1.08M	$ -984.79K	$ -236.87K	$ -765.84K	$ -1.41M	$ -1.67M
Normalized Income	$ -297.06K	-	-	$ -765.84K	$ -1.03M	$ -1.67M
Interest Expense	-	-	-	-	-	$ 322.47K
EBIT	$ -1.07M	$ -984.79K	$ -236.87K	$ -765.84K	$ -1.03M	$ -1.35M
EBITDA	$ -998.50K	$ -953.50K	$ -205.54K	$ -734.42K	$ -1.00M	$ -1.23M

Currency in USD

Vicapsys Life Sciences Earnings and Revenue History

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing